Australia | Dec 06 2023
A Listed Investment Company (LIC) is a listed investment vehicle that offers investors access to a diversified portfolio of shares in other companies also listed on the stock market. Also known as Listed Investment Trusts or Listed Managed Investments.
For comprehensive comparative data tables for LICs please see attached (logon first).
LMI Market News
Rob Luciano Resigns from VGI Partners
During the month, Rob Luciano resigned from VGI Partners, a wholly owned subsidiary of Regal Partners Limited ((RPL)). Rob was the Founder and Chief Investment Officer of VGI Partners and Portfolio Manager of VGI Partners Global Investments Limited ((VG1)).
Rob’s resignation follows a six-month period of sabbatical leave.
Marco Anselmi and Simon Birrell took over as Portfolio Manager’s for the VG1 portfolio when Rob was on leave and will continue in this position now Rob has resigned with oversight from the CIO of Regal Funds Management, Phillip King.
PM Capital to be Acquired by Regal Partners
On 3 November 2023, PM Capital Global Opportunities Fund Limited ((PGF)) confirmed rumours that the investment manager of PGF, PM Capital Limited, has entered into an agreement with Regal Partners Limited ((RPL)), in which RPL will acquire 100% of the issued shares of PM Capital Limited.
Paul Moore, Chief Investment Officer (CIO) of PM Capital Limited, will continue to manage the PGF portfolio and investment team with no changes to the investment strategy. The acquisition will include an upfront cash component of $20 million with deferred RPL scrip consideration of $130 million, with the conversion of scrip consideration subject to longterm arrangements, including the continued employment of Paul Moore and certain revenue and FUM targets among other conditions.
Scrip consideration will occur at various dates between 30 September 2024 and 1 July 2028, effectively locking in Paul Moore’s employment for over four years.
PL8 Announces SPP
Plato Income Maximiser Limited ((PL8)) has announced a Share Purchase Plan (SPP) providing shareholders the opportunity to acquire between $2,500 and $30,000 worth of PL8 shares. The offer opened on 23 November 2023 and is scheduled to close on 11 December 2023. Shares under the SPP will be issued at the lower of:
-$1.04 per share, which represents the pre-tax NTA per share plus the franking credit balance per share on 20 November 2023; and the pre-tax NTA on the day the SPP closes (scheduled for 11 December 2023) plus the franking credit balance of $0.024 per share on 20 November 2023.
-The maximum issue price of $1.04 per share represented a 15.4% discount to the close price of PL8 on 20 November 2023, the business day prior to the announcement. Shares issued under the SPP will be entitled to the December monthly dividend of $0.0055 per share.
-PL8 has been trading at a premium to pre-tax NTA for a prolonged period of time. The SPP provides PL8 shareholders the opportunity to acquire additional shares at pre-tax NTA. In response to the announcement, the share price declined towards the pre-tax NTA.
In a recent webinar, the Portfolio Manager, Dr. Don Hamson, acknowledged the investment strategy was close to capacity, which may limit the ability of the Company to undertake further capital raisings.
The Company believes the profits reserves and franking credit balance are sufficient to maintain the current level of monthly dividends with any additional capital raised.
RYD Commence a Review to Address Discount
At it’s AGM, Ryder Capital Limited ((RYD)) stated that the Board has commenced a review to address the discount at which RYD has traded and the low levels of liquidity. The Company will seek to provide a solution whereby shareholders are able to realise their investment at NTA. The Company anticipates it will be in a position to update shareholders no later than February 2024 with the outcomes of the review and the proposed course of action.
RYD has traded at a discount to pre-tax NTA for the majority of the Company’s history. The options available to RYD will include restructuring to an open-ended listed fund, delisting and operating as an unlisted unit trust or winding up the company and returning capital to shareholders.
MXT Announces Placement and UPP
On 29 November 2023, Metrics Master Income Trust ((MXT)) announced a Placement to wholesale and sophisticated investors and a Unit Purchase Plan (UPP). New units for both the Placement and UPP will be issued at $2.00 per unit.
The Trust raised ~$196.4 million through the Placement with the Trust to issue 98.2 million new units. The UPP offers investors the opportunity to acquire up to $30,000 of new units. The UPP is scheduled to open 11 December 2023 and close on 30 January 2024.
Capital raised will be invested in accordance with the investment mandate and target return. MXT invests in the MCP Wholesale Investment Trust, which in turn invests in three wholesale funds managed by Metrics Credit Partners Pty Ltd:
(1) Metrics Credit Partners Diversified Australian Senior Loan Fund (DASLF) (60%); (2) MCP Secured Private Debt Fund II (SPDF II) (20%); and (iii) MCP Real Estate Debt Fund (REDF) (20%). The wholesale funds provide exposure to the Australian corporate loan market but with differing risk-return investment profiles and target loan investments.
MXT investors have benefited from the increasing interest rate environment with distributions for the FY23 period increasing 77% on the prior year with the Trust currently offering attractive risk-adjusted returns.
HM1 Refreshes Conference Portfolio
The annual Hearts & Minds Investment Leaders Conference was held during the month with Hearts & Minds Investments Limited ((HM1)) refreshing the Conference Portfolio with the stock picks from the Conference Managers.
The Conference Portfolio represents 35% of the HM1 portfolio. The Conference Portfolio is tabled below.
WAM Poised for a Dividend Cut
WAM Capital Limited ((WAM)) Profits Reserve was below the semiannual dividend amount at 31 October 2023 which means the portfolio will need to finish the year strongly to stave off a dividend cut.
The maintenance of the annual dividend amount amongst a difficult market for small industrials and a significantly increased number of shares on issue in recent years has seen the Profits Reserve become depleted.
As was highlighted in the Chair’s address at the recent AGM, “to sustain a fully franked dividend of 15.5 cents per share, at the current net asset level, the investments portfolio would need to be approximately 16% per annum, grossed-up for expenses and fees.”
This is a high level of returns to generate consistently, particularly in the current market environment, resulting in heightened risks regarding the prospects of a dividend cut in the near-term.
TGF Board Changes
Ben Cleary and Todd Warren have stepped down from the Board of Tribeca Global Natural Resources Limited ((TGF)) to focus on the management of the portfolio. Following the resignation of Ben and Todd, the Board comprises three independent Directors. Rebecca O’Dwyer has taken over the position of Chair of the Board from Bruce Loveday, who remains a Director on the Board.
In the Chairman’s address at the AGM in November, the Chairman detailed that the Board has reviewed the structural options to address the discount. The Board concluded that the available options are either infeasible or pose a prohibitive cost to shareholders. As such, the Company has no intentions to restructure to address the discount to NTA.
FPC Announces SPP
During the month, Fat Prophets Global Contrarian Fund Limited ((FPC)) announced a Share Purchase Plan (SPP), providing shareholders the opportunity to acquire up to $30,000 of FPC shares at the lower of $0.90 per share or the five-day VWAP during the last five trading days prior to, and including, the closing date for the SPP.
The offer opened on 20 November 2023 and is scheduled to close on 11 December 2023.
Capital raised will be invested in accordance with the investment objectives adopted by the Company, with the Company believing shareholders will benefit from the increased size of the Company. This is the second SPP undertaken by the Company in the last 12-months and comes after the Company undertook an Equal Access Buy-Back (EABB) scheme which resulted in the Company buying back over 13 million shares in total across the three tranches.
The EABB scheme was implemented to allow shareholders the ability to convert their FPC shares to units in Fat Prophets Global High Conviction Hedge Fund ((FATP)), an ETMF managed by the Manager of the FPC portfolio. FPC shares were bought back at a price equal to a 3% discount to the NAV of the Company.
In recent years, the Company has tried to grow through SPP’s while at the same time reducing the size of the Company through the EABB as well as implementing an on-market share buy-back in March 2023 to buy back shares when trading at a discount of more than 10%. It may be time for the Company to decide what its ultimate objective is with recent initiatives seeming to be at odds with one another.
WQG Declared Dividend of 1.68 cents per share for September Quarter and Reaffirms Dividend Guidance
On 15 November 2023, WCM Global Growth Limited ((WCM)) announced a dividend of 1.68 cents per share, fully franked, for the September quarter 2023. The Board also reaffirmed its intention to pay dividends of 5.22 cents per share, fully franked, for the next three quarters.
This will take dividends for the FY24 period to 6.9 cents per share, which represents a dividend yield of 6.3% (9.0% grossed-up) based on the share price at 31 October 2023.
In addition to reaffirming the dividend intentions for the FY24 period, the Board announced its intention to pay a dividend of 1.77 cents per share for the September quarter 2024, which will be the largest quarterly dividend paid if the guidance is followed over the next 12-months.
WHF Declares Interim Dividend of 10.25 cents per share
During the month, Whitefield Industrials Limited ((WHF)) released its 1H’FY24 results for the period ending 30 September 2023. The Company reported Investment Income of $12.15 million, up 15.8% on the pcp and NPAT of $907 million, up 16.7% on the pcp.
The Company stated that dividend growth was widely spread across a large number of holdings, with notable dividend growth from AGL, IAG, Suncorp, QBE, Promedicus, Computershare, Carsales, Wisetech and Macquarie Group.
The Company declared an interim dividend of 10.25 cents per share with the Company noting that the continuing growth in EPS will increasingly position the Company to consider increases to dividends in future years.
Jennifer Westacott AO Joins FGG Board
Future Generation Global Limited ((FGG)) announced that Jennifer Westacott AO will join the Board and be appointed Chair, effective 27 November 2023. Jennifer will assume the role of Chair from the acting Chair, Geoff Wilson AO, who will remain on the Board as a Non-Independent Director.
Jennifer was the Chief Executive of the Business Council of Australia from February 2011 to October 2023. Jennifer is currently Chancellor of the University of Western Sydney, a Non-executive Director of Wesfarmers, Chair of the Western Parkland City Authority and Chair of the Board of Studio Schools of Australia. Jennifer is also a patron of Mental Health Australia, co-patron of Pride in Diversity and a patron of the Pinnacle Foundation.
LSX Increases Position in Plutonic
During the month, Lion Selection Group Limited ((LSX)) announced it had made a follow-on investment in Plutonic Limited, committing to invest $2 million in a recent capital raising by the company.
The investment will increase LSX’s holding in Plutonic from 31.1% to between 37% and 48% depending on the size of the capital raise with the company seeking to raise between $3 million and $5 million at $0.10 per share. The Company stated in its announcement - “Plutonic is a key investment to Lion for the unique leverage to discovery it provides. A discovery of gold or copper mineralisation at Champion could result in meaningful value creation, which Lion has a strong exposure to via its
high percentage ownership. This investment has been made for a low cost and currently represents a small proportion of Lion’s overall value. Plutonic is unlisted so this exposure is a unique aspect of Lion that is not easily obtainable elsewhere.”
LSX continues to have a large cash balance which it is seeking to deploy in a market which has weakened.
For more data, info and details, download the document attached via the top of this story.
Independent Investment Research, “IIR”, is an independent investment research house based in Australia and the United States. IIR specialises in the analysis of high quality commissioned research for Brokers, Family Offices and Fund Managers. IIR distributes its research in Asia, United States and the Americas. IIR does not participate in any corporate or capital raising activity and therefore it does not have any inherent bias that may result from research that is linked to any corporate/ capital raising activity.
IIR was established in 2004 under Aegis Equities Research Group of companies to provide investment research to a select group of retail and wholesale clients. Since March 2010, IIR (the Aegis Equities business was sold to Morningstar) has operated independently from Aegis by former Aegis senior executives/shareholders to provide clients with unparalleled research that covers listed and unlisted managed investments, listed companies, structured products, and IPOs. IIR takes great pride in the quality and independence of our analysis, underpinned by high caliber staff and a transparent, proven and rigorous research methodology.
INDEPENDENCE OF RESEARCH ANALYSTS
Research analysts are not directly supervised by personnel from other areas of the Firm whose interests or functions may conflict with those of the research analysts. The evaluation and appraisal of research analysts for purposes of career advancement, remuneration and promotion is structured so that non-research personnel do not exert inappropriate influence over analysts.
Supervision and reporting lines: Analysts who publish research reports are supervised by, and report to, Research Management. Research analysts do not report to, and are not supervised by, any sales personnel nor do they have dealings with Sales personnel
Evaluation and remuneration: The remuneration of research analysts is determined on the basis of a number of factors, including quality, accuracy and value of research, productivity, experience, individual reputation, and evaluations by investor clients.
INDEPENDENCE – ACTIVITIES OF ANALYSTS
IIR restricts research analysts from performing roles that could prejudice, or appear to prejudice, the independence of their research.
Pitches: Research analysts are not permitted to participate in sales pitches for corporate mandates on behalf of a Broker and are not permitted to prepare or review materials for those pitches. Pitch materials by investor clients may not contain the promise of research coverage by IIR.
No promotion of issuers’ transactions: Research analysts may not be involved in promotional or marketing activities of an issuer of a relevant investment that would reasonably be construed as representing the issuer. For this reason, analysts are not permitted to attend “road show” presentations by issuers that are corporate clients of the Firm relating to offerings of securities or any other investment banking transaction from that our clients may undertake from time to time. Analysts may, however, observe road shows remotely, without asking questions, by video link or telephone in order to help ensure that they have access to the same information as their investor clients.
Widely-attended conferences: Analysts are permitted to attend and speak at widely-attended conferences at which our firm has been invited to present our views. These widely-attended conferences may include investor presentations by corporate clients of the Firm.
Other permitted activities: Analysts may be consulted by Firm sales personnel on matters such as market and industry trends, conditions and developments and the structuring, pricing and expected market reception of securities offerings or other market operations. Analysts may also carry out preliminary due diligence and vetting of issuers that may be prospective research clients of ours.
INDUCEMENTS AND INAPPROPRIATE INFLUENCES
IIR prohibits research analysts from soliciting or receiving any inducement in respect of their publication of research and restricts certain communications between research analysts and personnel from other business areas within the Firm including management, which might be perceived to result in inappropriate influence on analysts’ views.
Remuneration and other benefits: IIR procedures prohibit analysts from accepting any remuneration or other benefit from an issuer or any other party in respect of the publication of research and from offering or accepting any inducement (including the selective disclosure by an issuer of material information not generally available) for the publication of favourable research. These restrictions do not preclude the acceptance of reasonable hospitality in accordance with the Firm’s general policies on entertainment, gifts and corporate hospitality.
This publication has been prepared by Independent Investment Research (Aust) Pty Limited trading as Independent Investment Research (“IIR”) (ABN 11 152 172 079), an corporate authorised representative of Australian Financial Services Licensee (AFSL no. 410381. IIR has been commissioned to prepare this independent research report (the “Report”) and will receive fees for its preparation. Each company specified in the Report (the “Participants”) has provided IIR with information about its current activities. While the information contained in this publication has been prepared with all reasonable care from sources that IIR believes are reliable, no responsibility or liability is accepted by IIR for any errors, omissions or misstatements however caused. In the event that updated or additional information is issued by the “Participants”, subsequent to this publication, IIR is under no obligation to provide further research unless commissioned to do so. Any opinions, forecasts or recommendations reflects the judgment and assumptions of IIR as at the date of publication and may change without notice. IIR and each Participant in the Report, their officers, agents and employees exclude all liability whatsoever, in negligence or otherwise, for any loss or damage relating to this document to the full extent permitted by law. This publication is not and should not be construed as, an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. Any opinion contained in the Report is unsolicited general information only. Neither IIR nor the Participants are aware that any recipient intends to rely on this Report or of the manner in which a recipient intends to use it. In preparing our information, it is not possible to take into consideration the investment objectives, financial situation or particular needs of any individual recipient. Investors should obtain individual financial advice from their investment advisor to determine whether opinions or recommendations (if any) contained in this publication are appropriate to their investment objectives, financial situation or particular needs before acting on such opinions or recommendations. This report is intended for the residents of Australia. It is not intended for any person(s) who is resident of any other country. This document does not constitute an offer of services in jurisdictions where IIR or its affiliates do not have the necessary licenses. IIR and/or the Participant, their officers, employees or its related bodies corporate may, from time to time hold positions in any securities included in this Report and may buy or sell such securities or engage in other transactions involving such securities. IIR and the Participant, their directors and associates declare that from time to time they may hold interests in and/or earn brokerage, fees or other benefits from the securities mentioned in this publication.
IIR, its officers, employees and its related bodies corporate have not and will not receive, whether directly or indirectly, any commission, fee, benefit or advantage, whether pecuniary or otherwise in connection with making any statements and/or recommendation (if any), contained in this Report. IIR discloses that from time to time it or its officers, employees and related bodies corporate may have an interest in the securities, directly or indirectly, which are the subject of these statements and/or recommendations (if any) and may buy or sell securities in the companies mentioned in this publication; may affect transactions which may not be consistent with the statements and/or recommendations (if any) in this publication; may have directorships in the companies mentioned in this publication; and/or may perform paid services for the companies that are the subject of such statements and/or recommendations (if any). However, under no circumstances has IIR been influenced, either directly or indirectly, in making any statements and/or recommendations (if any) contained in this Report. The information contained in this publication must be read in conjunction with the Legal Notice that can be located at http://www.independentresearch.com.au/Public/Disclaimer.aspx.
Content included in this article is not by association the view of FNArena (see our disclaimer).
Find out why FNArena subscribers like the service so much: "Your Feedback (Thank You)" - Warning this story contains unashamedly positive feedback on the service provided.
FNArena is proud about its track record and past achievements: Ten Years On